|
1.
|
|
24 p, 1.5 MB |
Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group
/
Chotiyarnwong, P. (Mahidol University) ;
McCloskey, E. V. (University of Sheffield) ;
Harvey, N. C. (University of Southampton) ;
Lorentzon, M. (Australian Catholic University) ;
Prieto-Alhambra, Daniel (Universitat Autònoma de Barcelona) ;
Abrahamsen, Bo (Holbæk Hospital (Dinamarca)) ;
Adachi, Jonathan D (St Joseph's Healthcare-McMaster University) ;
Borgström, F. (Karolinska Institutet (Estocolm, Suècia)) ;
Bruyère, Olivier (Université de Liège) ;
Carey, J. J. (Galway University Hospitals) ;
Clark, P. (Universidad Nacional Autónoma de México) ;
Cooper, Cyrus (University of Southampton) ;
Curtis, E. M. (University of Southampton) ;
Dennison, E. M (University of Southampton) ;
Diaz-Curiel, Manuel (Hospital Universitario Fundación Jiménez Díaz) ;
Dimai, Hans Peter (Medical University of Graz) ;
Grigorie, D. (National Institute of Endocrinology) ;
Hiligsmann, M. (Maastricht University) ;
Khashayar, P. (Imec and Ghent University) ;
Lewiecki, E. M. (New Mexico Clinical Research & Osteoporosis Center) ;
Lips, P. (Vrije Universiteit Amsterdam) ;
Lorenc, R. S. (Multidisciplinary Osteoporosis Forum (Polònia)) ;
Ortolani, S. (IRCCS Istituto Auxologico (Itàlia)) ;
Papaioannou, A. (GERAS Centre for Aging Research (Canadà)) ;
Silverman, Stuart (Cedars-Sinai Medical Center) ;
Sosa-Henríquez, Manuel (Universidad de Las Palmas de Gran Canaria) ;
Szulc, P. (Hôpital Edouard Herriot (França)) ;
Ward, K. A. (University of Southampton) ;
Yoshimura, N. (University of Tokyo) ;
Kanis, John A (Australian Catholic University)
The IOF Epidemiology and Quality of Life Working Group has reviewed the potential role of population screening for high hip fracture risk against well-established criteria. The report concludes that such an approach should strongly be considered in many health care systems to reduce the burden of hip fractures. [...]
2022 -  10.1007/s11657-022-01117-6
Archives of Osteoporosis, Vol. 17 (june 2022)
|
|
|
2.
|
|
16 p, 967.2 KB |
Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs
/
Fuggle, N. R. (University of Southampton) ;
Cooper, Cyrus (University of Oxford) ;
Harvey, N. C. (University of Southampton) ;
Al-Daghri, Nasser (King Saud University) ;
Brandi, Maria Luisa (University Hospital of Florence) ;
Bruyère, Olivier (WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, Liège, Belgium) ;
Cano Sánchez, Antonio (University of Valencia) ;
Dennison, E. M. (University of Southampton) ;
Díez Pérez, Adolfo (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Kaufman, J.-M. (Universitair Ziekenhuis Gent) ;
Palacios, S. (The Palacios Institute of Women's Health, Madrid) ;
Prieto-Alhambra, D. (University of Oxford) ;
Rozenberg, S. (CHU St Pierre, Bruxelles) ;
Thomas, T. (CHU de Saint-Etienne, France) ;
Tremollieres, F. (Toulouse University Hospital) ;
Rizzoli, R. (Hôpitaux Universitaires Genève) ;
Kanis, John A (Australian Catholic University) ;
Reginster, Jean-Yves (King Saud University) ;
Universitat Autònoma de Barcelona
The incidence of osteoporosis and cardiovascular disease increases with age, and there are potentially shared mechanistic associations between the two conditions. It is therefore highly relevant to understand the cardiovascular implications of osteoporosis medications. [...]
2020 - 10.1007/s40265-020-01364-2
Drugs, Vol. 80 (july 2020) , p. 1537-1552
|
|
|
3.
|
|
12 p, 639.3 KB |
Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
/
Kanis, John A. (Australian Catholic University. Mary McKillop Health Institute) ;
Harvey, N. C. (University of Southampton. MRC Lifecourse Epidemiology Unit) ;
McCloskey, Eugene (MRC and Arthritis Research UK Centre for Integrated Research in Musculoskeletal Ageing Mellanby) ;
Bruyère, Olivier (University of Liège. World Health Organization Collaborating Center for the Public Health Aspects of Musculoskeletal Health and Aging, Department of Public Health, Epidemiology and Health Economics) ;
Veronese, Nicola (Neuroscience Institute (Pàdua, Itàlia). Aging Branch) ;
Lorentzon, Mattias (Sahlgrenska University Hospital (Suècia)) ;
Cooper, Cyrus (University of Oxford. NIHR Musculoskeletal Biomedical Research Unit) ;
Rizzoli, Rene (Geneva University Hospitals (Suïssa)) ;
Adib, Gemma (Syrian National Osteoporosis Society) ;
Al-Daghri, Nasser (King Saud University. Chair for Biomarkers of Chronic Diseases, Biochemistry Dept., College of Science) ;
Campusano, C. (Universidad de los Andes. Clinica Universidad de los Andes and Faculty of Medicine) ;
Chandran, Manju (Singapore General Hospital, ACADEMIA. Osteoporosis and Bone Metabolism Unit, Department of Endocrinology) ;
Dawson-Hughes, Bess (Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University) ;
Javaid, K. (University of Oxford. NIHR Musculoskeletal Biomedical Research Unit) ;
Jiwa, Famida (Osteoporosis Canada. Chair of the Committee of Patients Societies at the International Osteoporosis Foundation) ;
Johansson, H. (Australian Catholic University. Mary McKillop Health Institute) ;
Lee, J. K. (Beacon International Specialist Centre, Petaling Jaya, Malaysia) ;
Liu, Emilia (Australian Catholic University. Mary McKillop Health Institute) ;
Messina, Osvaldo D. (Cosme Argerich. IRO Medical Research Center, Buenos Aires and Rheumatology section) ;
Mkinsi, Ouafa (Ibn Rochd University Hospital. Department of Rheumatology) ;
Pinto, Daniel (Northwestern University. Department of Medical Social Sciences, Feinberg School of Medicine) ;
Prieto-Alhambra, Daniel (Universitat Autònoma de Barcelona) ;
Saag, Kenneth G (University of Alabama at Birmingham) ;
Xia, W. (Chinese Academy of Medical Sciences & Peking Union Medical College. Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital) ;
Zakraoui, Leith (University Tunis Manar and Hôpital Mongi-Slim. Service de Rhumatologie) ;
Reginster, Jean-Yves (University of Liège. Department of Public Health, Epidemiology and Health Economics)
Guidance is provided in an international setting on the assessment and specific treatment of postmenopausal women at low, high and very high risk of fragility fractures. The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis published guidance for the diagnosis and management of osteoporosis in 2019. [...]
2020 - 10.1007/s00198-019-05176-3
Osteoporosis International, Vol. 31 (2020) , p. 1-12
|
|
|
4.
|
|
11 p, 318.1 KB |
Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment : results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)
/
Hiligsmann, M. (CAPHRI Care and Public Health Research Institute) ;
Cornelissen, D. (CAPHRI Care and Public Health Research Institute) ;
Vrijens, B. (Université de Liège) ;
Abrahamsen, Bo (University of Southern Denmark) ;
Al-Daghri, Nasser (King Saud University) ;
Biver, E. (Hôpitaux Universitaires de Genève) ;
Brandi, Maria Luisa (Università di Firenze) ;
Bruyère, Olivier (Université de Liège) ;
Burlet, N. (Sanofy Lyon) ;
Cooper, Cyrus (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Cortet, Bernard (Centre Hospitalier Universitaire de Lille) ;
Dennison, E. M. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Díez Pérez, Adolfo (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Gasparik, A. (University of Medicine, Pharmacy, Science and Technology of Targu Mures) ;
Grosso, A. (Hôpitaux Universitaires de Genève) ;
Hadji, Peyman (Frankfurt Centre of Bone Health) ;
Halbout, P. (International Osteoporosis Foundation) ;
Kanis, John A (University of Sheffield Medical School) ;
Kaufman, J. M. (Universitair Ziekenhuis Gent) ;
Laslop, A. (Austrian Federal Office for Safety in Health Care) ;
Maggi, Stefania (CNR Aging Branch - Institute of Neuroscience, Padova) ;
Rizzoli, R. (Hôpitaux Universitaires de Genève) ;
Thomas, T. (CHU Saint-Etienne) ;
Tuzun, S. (İstanbul University Cerrahpaşa) ;
Vlaskovska, M. (Medical University Sofia) ;
Reginster, Jean-Yves (King Saud University) ;
Universitat Autònoma de Barcelona
Summary: Many patients at increased risk of fractures do not take their medication appropriately, resulting in a substantial decrease in the benefits of drug therapy. Improving medication adherence is urgently needed but remains laborious, given the numerous and multidimensional reasons for non-adherence, suggesting the need for measurement-guided, multifactorial and individualized solutions. [...]
2019 - 10.1007/s00198-019-05104-5
Osteoporosis International, Vol. 30 Núm. 11 (january 2019) , p. 2155-2165
|
|
|
5.
|
|
11 p, 634.6 KB |
Diacerein : Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO
/
Pavelka, Karel (Charles University) ;
Bruyère, Olivier (Liège, Belgium) ;
Cooper, Cyrus (Southampton, UK) ;
Kanis, John A. (Sheffield, UK) ;
Leeb, Burkhard F. (State Hospital Stockerau) ;
Maheu, Emmanuel (St-Antoine Hospital) ;
Martel-Pelletier, Johanne ;
Monfort, Jordi (Hospital del Mar (Barcelona, Catalunya)) ;
Pelletier, Jean-Pierre (University of Montreal Hospital Research Centre (CRCHUM)) ;
Rizzoli, René (Geneva University Hospitals (Suïssa)) ;
Reginster, Jean-Yves (Université de Liège) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Diacerein is a symptomatic slow-acting drug in osteoarthritis (SYSADOA) with anti-inflammatory, anti-catabolic and pro-anabolic properties on cartilage and synovial membrane. It has also recently been shown to have protective effects against subchondral bone remodelling. [...]
2016 - 10.1007/s40266-016-0347-4
Drugs & Aging, Vol. 33 (february 2016) , p. 75-85
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
